These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 6873010)
1. Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy. Goldfarb S; Pugh TD; Koen H; He YZ Environ Health Perspect; 1983 Apr; 50():149-61. PubMed ID: 6873010 [TBL] [Abstract][Full Text] [Related]
2. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. Vesselinovitch SD; Mihailovich N Cancer Res; 1983 Sep; 43(9):4253-9. PubMed ID: 6871863 [TBL] [Abstract][Full Text] [Related]
3. Hepatocarcinogenesis in the mouse. Combined morphologic-stereologic studies. Koen H; Pugh TD; Goldfarb S Am J Pathol; 1983 Jul; 112(1):89-100. PubMed ID: 6190407 [TBL] [Abstract][Full Text] [Related]
4. Presence of alpha-fetoprotein-positive cells in hepatocellular foci and microcarcinomas induced by single injections of diethylnitrosamine in infant mice. Koen H; Pugh TD; Nychka D; Goldfarb S Cancer Res; 1983 Feb; 43(2):702-8. PubMed ID: 6184154 [TBL] [Abstract][Full Text] [Related]
5. Cell proliferation and regulation of negative growth factors in mouse liver foci. Moser GJ; Wolf DC; Harden R; Standeven AM; Mills J; Jirtle RL; Goldsworthy TL Carcinogenesis; 1996 Sep; 17(9):1835-40. PubMed ID: 8824503 [TBL] [Abstract][Full Text] [Related]
6. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay. Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742 [TBL] [Abstract][Full Text] [Related]
7. Centrilobular distribution of diethylnitrosamine-induced hepatocellular foci in the mouse. Koen H; Pugh TD; Goldfarb S Lab Invest; 1983 Jul; 49(1):78-81. PubMed ID: 6865333 [TBL] [Abstract][Full Text] [Related]
8. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver. Moser GJ; Wolf DC; Goldsworthy TL Toxicol Pathol; 1997; 25(3):275-83. PubMed ID: 9210259 [TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine. Moore MR; Drinkwater NR; Miller EC; Miller JA; Pitot HC Cancer Res; 1981 May; 41(5):1585-93. PubMed ID: 7214332 [TBL] [Abstract][Full Text] [Related]
10. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice. Ward JM; Rice JM; Creasia D; Lynch P; Riggs C Carcinogenesis; 1983 Aug; 4(8):1021-9. PubMed ID: 6872148 [TBL] [Abstract][Full Text] [Related]
11. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital. Tamano S; Merlino GT; Ward JM Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571 [TBL] [Abstract][Full Text] [Related]
12. Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643. Marsman DS; Popp JA Carcinogenesis; 1994 Jan; 15(1):111-7. PubMed ID: 7507413 [TBL] [Abstract][Full Text] [Related]
13. Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility. Greaves P; Irisarri E; Monro AM J Natl Cancer Inst; 1986 Mar; 76(3):475-84. PubMed ID: 2869179 [TBL] [Abstract][Full Text] [Related]
14. Rat hepatocarcinogenesis induced by N-nitrosodiethylamine and N-nitrosomorpholine continuously administered at low doses. From basophilic areas of hepatocytes to hepatocellular tumors. Cortinovis C; Klimek F; Nogueira E Am J Pathol; 1991 Nov; 139(5):1157-71. PubMed ID: 1951631 [TBL] [Abstract][Full Text] [Related]
15. Histochemical characterization of focal hepatic lesions induced by single diethylnitrosamine treatment in infant mice. Vesselinovitch SD; Hacker HJ; Bannasch P Cancer Res; 1985 Jun; 45(6):2774-80. PubMed ID: 2859111 [TBL] [Abstract][Full Text] [Related]
16. Rapid induction of preneoplastic liver foci in embryonal turkey liver by diethylnitrosamine. Enzmann H; Kühlem C; Kaliner G; Löser E; Bannasch P Toxicol Pathol; 1995; 23(5):560-9. PubMed ID: 8578099 [TBL] [Abstract][Full Text] [Related]
17. Sequential hepatic histologic and histochemical changes produced by diethylnitrosamine in the rhesus monkey. Ruebner BH; Michas C; Kanayama R; Bannasch P J Natl Cancer Inst; 1976 Dec; 57(6):1261-7. PubMed ID: 187798 [TBL] [Abstract][Full Text] [Related]
18. Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability. Zerban H; Radig S; Kopp-Schneider A; Bannasch P Carcinogenesis; 1994 Nov; 15(11):2467-73. PubMed ID: 7955093 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of altered liver cell foci and persistent nodule growth by vanadium during diethylnitrosamine-induced hepatocarcinogenesis in rats. Bishayee A; Chatterjee M Anticancer Res; 1995; 15(2):455-61. PubMed ID: 7763021 [TBL] [Abstract][Full Text] [Related]
20. Dose-related induction of hepatic preneoplastic lesions by diethylnitrosamine in C57BL/6 mice. Kushida M; Kamendulis LM; Peat TJ; Klaunig JE Toxicol Pathol; 2011 Aug; 39(5):776-86. PubMed ID: 21628716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]